Authors
Meletios A Dimopoulos, Pieter Sonneveld, Nelson Leung, Giampaolo Merlini, Heinz Ludwig, Efstathios Kastritis, Hartmut Goldschmidt, Douglas Joshua, Robert Z Orlowski, Raymond Powles, David H Vesole, Laurent Garderet, Hermann Einsele, Antonio Palumbo, Michele Cavo, Paul G Richardson, Philippe Moreau, Jesús San Miguel, S Vincent Rajkumar, Brian GM Durie, Evangelos Terpos
Publication date
2016/5/1
Journal
Journal of Clinical Oncology
Volume
34
Issue
13
Pages
1544-1557
Publisher
American Society of Clinical Oncology
Description
Purpose
The aim of the International Myeloma Working Group was to develop practical recommendations for the diagnosis and management of multiple myeloma–related renal impairment (RI).
Methods
Recommendations were based on published data through December 2015, and were developed using the system developed by the Grading of Recommendation, Assessment, Development, and Evaluation Working Group.
Recommendations
All patients with myeloma at diagnosis and at disease assessment should have serum creatinine, estimated glomerular filtration rate, and electrolytes measurements as well as free light chain, if available, and urine electrophoresis of a sample from a 24-hour urine collection (grade A). The Chronic Kidney Disease Epidemiology Collaboration, preferably, or the Modification of Diet in Renal Disease formula should be used for the evaluation of estimated glomerular filtration rate in …
Scholar articles
MA Dimopoulos, P Sonneveld, N Leung, G Merlini… - Journal of Clinical Oncology, 2016